9th Circ. Skeptical Of Coverage For Co.'s Opioid Probe Costs

A Ninth Circuit panel seemed poised to secure U.S. Specialty Insurance Co.'s win in a coverage dispute with an opioid drugmaker seeking to recover $2.4 million it spent responding to government...

Already a subscriber? Click here to view full article